SynthesisJournal of diabetes research2026
Diabetic Retinopathy and Cognitive Dysfunction in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Associations and Clinical Implications.
Synthesis in Journal of diabetes research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Diabetic Retinopathy and Cognitive Dysfunction in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Associations and Clinical Implications.Journal of diabetes research · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsType 2 diabetes mellitus (T2DM) is linked to both diabetic retinopathy (DR) and cognitive impairment, yet the consistency and modifiers of this relationship remain unclear. This systematic review and meta-analysis are aimed at quantifying the association between DR and cognitive dysfunction in T2DM and explore variations by cognitive subtype, diabetes duration, follow-up time, and assessment methods. MATERIALS AND
methodsWe searched PubMed, Embase, Web of Science, and Chinese databases from 2000 to March 2025. Observational studies comparing cognitive outcomes in T2DM patients with and without DR were included. Data were pooled using random-effects models.
resultsForty-eight studies were included. Cross-sectional studies showed a strong association (OR = 2.04, 95% CI: 1.72-2.42; I
conclusionDR is significantly associated with cognitive impairment in T2DM, particularly dementia and its subtypes. The association is influenced by study design, diabetes duration, follow-up time, and assessment method. DR may serve as a research-level risk signal for cerebral microvascular damage, warranting further prospective studies to validate its clinical utility.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.